Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942.
      Google Scholar   
Citation:
J Clin Oncol vol 25 (18) 2567-72
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
492   507   555  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA-25224, CA-35101, CA-35103, CA-35113, CA-35195, CA-35269, CA-35415, CA-35431, CA-35448, CA-37404, CA-37417, CA-52352, CA-60276, CA-63848  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N9942
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Adenocarcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Combined Modality Therapy, Deoxycytidine, Disease Progression, Female, Humans, Male, Middle Aged, Pancreatic Neoplasms, Radiotherapy Dosage, Survival Rate, Treatment Outcome